Literature DB >> 18940165

[Hernias as medical disease].

Jakob Burcharth1, Jacob Rosenberg.   

Abstract

Abnormal systemic collagen metabolism is thought to dispose to the development of hernias. Studies have shown that a reduced type-I/III collagen ratio predisposes to the development of hernias. Patient groups with reduced type-I/III collagen ratio and consequently increased risk of herniation include patients with Ehlers-Danlos, Marfans syndrome, osteogenesis imperfecta, cutis laxa, and patients with abdominal aortic aneurysms, colonic diverticula or stress urinary incontinence. Looking ahead, the perspective may be individualization of the operative technique for patients with a hernia, depending on their collagen profile.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18940165

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  5 in total

1.  Groin hernia subtypes are associated in patients with bilateral hernias: a 14-year nationwide epidemiologic study.

Authors:  Jakob Burcharth; Kristoffer Andresen; Hans-Christian Pommergaard; Jacob Rosenberg
Journal:  Surg Endosc       Date:  2014-10-16       Impact factor: 4.584

2.  Osteogenesis imperfecta and congenital diaphragmatic hernia.

Authors:  Shamik Dholakia; Stuart Cleeve
Journal:  BMJ Case Rep       Date:  2013-01-22

3.  Port-site transversus abdominis fascia closure reduced the incidence of incisional hernia following retroperitoneal laparoscopic nephrectomy.

Authors:  A Takei; T Sazuka; K Nakamura; N Nihei; T Ichikawa
Journal:  Hernia       Date:  2016-05-26       Impact factor: 4.739

4.  Tobacco use is not associated with groin hernia repair, a population-based study.

Authors:  A Hemberg; H Holmberg; M Norberg; P Nordin
Journal:  Hernia       Date:  2017-05-11       Impact factor: 4.739

5.  Randomized trial of umbilical incisional hernia in high-risk patients: extraction of gallbladder through subxiphoid port vs. umbilical port after laparoscopic cholecystectomy.

Authors:  Min Li; Baoqiang Cao; Renhua Gong; Dengqun Sun; Peisong Zhang; Xudong Jiang; Yanfei Sheng
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-05-25       Impact factor: 1.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.